Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
Clinical trial NCT02957656 · COMPLETED
Trial details
- NCT number
- NCT02957656
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-06-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.